Micron Technologies Limited @ InformEx USA 2010, stand 2135

Published: 11-Feb-2010

Micron Technologies, the leading provider of particle size reduction for pharmaceutical ingredients, will be announcing the achievement of two major steps in the company history; first, the inauguration in a couple of months of a brand new facility in the US, located at Malvern, Pennsylvania, dedicated to the particle size reduction and material characterisation of active pharmaceutical ingredients; this 90,000ft2 state of the art facility designed for cGMP manufacturing will be equipped with several large units for micronisation of commercial volumes including potent compounds.
Second, Micron Technologies has invested in what is believed to be the largest micronisation suite under full containment available in the market; this unit will be ready for customers very soon and has the ability to fully contain small scale as well as large scale equipment to micronise potent and highly potent compounds.
Micronisation is the quickest, most reliable, reproducible and cost-effective technique to bring a poorly soluble drug to market and these investments will enhance Micron Technologies" leadership in particle size reduction and material characterisation.
  • Companies:
  • Catalent
  • Informa
See more

You may also like

Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Read more
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth
Manufacturing

Ardena acquires Catalent's US oral dose manufacturing facility, adding further bioanalytical services

The CRO/CDMO will now integrate its advanced late-stage and small-scale commercial oral drug product manufacturing services with an extended list of bioanalytical services, enhancing its offering to clients in the North American region
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Of data, devices and drug delivery

Ahead of Pharmapack Europe 2025 (22–23January, Paris, France), Dr Kevin Robinson (KSR) spoke with three pharma leaders about the big trends that will drive and influence the pharmaceutical sector in 2025
Finance

Novo Holdings completes acquisition of Catalent

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
Manufacturing

Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation

Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility
Manufacturing

Faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act, states CPHI Milan survey

CPHI Milan returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025
Pharmaceutical

CPHI Milan announces the finalists for 14 categories of the Pharma Awards

Awards for future leaders, women of the year and those at the heart of pharma will be handed out at the CPHI Pharma Awards ceremony
Subscribe now